Market Insider

RMD, AFRM, NVDA, BUD and more

Check out the companies making the biggest moves midday: Inspire Medical Systems , ResMed — Inspire Medical Systems and ResMed, which manufacture devices to treat obstructive sleep apnea, dropped 14% and 11%, respectively, following Friday's news that Eli Lilly 's weight loss drug tirzepatide reduced the severity of the...

Business News

Paramount+ to increase prices for its streaming plans

Paramount Global is hiking the price of its flagship streaming service as the company looks to turn around its business.The company said Monday it will raise the price of the Paramount+ with Showtime plan by $1 to $12.99 a month, and the price of its Paramount+ Essential option will...

Popular Posts

Featured Posts

Featured Author

Gregg Greenberg spent 14 years as a journalist at TheStreet.com where he wrote the highly popular column "The 5 Dumbest Things on Wall Street This Week". His work has appeared in magazines ranging from Glamour to ESPN the Magazine, and on humor sites such as Points in Case.

Fintech Review

With years of experience dissecting and evaluating the evolving fintech landscape, Fintech Review has become a trusted name in providing insightful, comprehensive, and unbiased reviews of tech-related financial products and services. From the latest advancements in blockchain and cryptocurrencies to cutting-edge payment platforms, robo-advisors, and beyond, Fintech Review keeps a pulse on the innovations that are redefining the financial industry.

Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility

Novo Nordisk's new manufacturing facility in Clayton, North Carolina.Courtesy: Novo NordiskNovo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other...

RMD, AFRM, NVDA, BUD and more

Check out the companies making the biggest moves midday: Inspire Medical Systems , ResMed — Inspire Medical Systems and ResMed, which manufacture devices to treat obstructive sleep apnea, dropped 14% and 11%, respectively, following Friday's news that Eli Lilly 's weight loss drug tirzepatide reduced the severity of the...